View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Novo Nordisk Pharmatech
17 September 2017

Novo Nordisk Pharmatech Showcases Recombinant Insulin at BioProcess International Conference and Exhibition

Novo Nordisk Pharmatech has announced it will be attending the BioProcess International conference and exhibition.

To be held from 25 September to 28 September at the Hynes Convention Center in Boston, Massachusetts, the conference is the largest exhibition devoted to biomanufacturing and brings you the science, technologies, and partners needed to accelerate promising biologics towards commercial success.

Novo Nordisk Pharmatech invites you to visit booth 1030 to discover its recombinant insulin for innovative biologics and pharmaceutical grade quaternary ammonium compounds.

The company is one of the leading worldwide suppliers of recombinant insulin and its products are key components in serum-free growth media for mammalian cells. They are approved by regulatory bodies worldwide, including the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) and manufactured to current good manufacturing practices (cGMP) standards, which guarantees:

  • Global regulatory compliance
  • Consistent high quality
  • Extensive regulatory documentation
  • Continuous availability
  • Secure global supply chain
  • High levels of service and support

Novo Nordisk Pharmatech delivers a proven record of product purity, reliability, and consistency. It can even tailor quality products for future therapies.

For more than 30 years, the National Research Council of Canada has been helping clients develop, optimise, scale-up and transfer bioprocesses to produce biologics and...
The Chinese hamster ovary (CHO) cell line is widely used for the production of recombinant proteins due to its high growth capacity and productivity, as...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology